Zenith

NAD+

A$399

Zenith NAD+ peptide pen
1000 mg / 2 mL · Dual-chamber
Longevity · Peptide Pen

NAD+

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in every cell of the human body, essential for energy metabolism, DNA repair and cellular signalling. NAD+ levels naturally decline with age. It has been studied in the context of mitochondrial function, cognitive clarity and cellular resilience. Suitability varies with health status and medications.

Cellular energy pathwayDNA repair cofactorPractitioner review recommended
From

A$399

1
Start Assessment

Supplied following assessment, bloodwork and practitioner review.

Strength

1000 mg

Volume

2 mL

Format

Dual-chamber pen

Administration

Subcutaneous injection

Storage

Refrigerated 2–8°C

Product code

NJ100

Overview

NAD+ is a critical coenzyme that serves as an electron carrier in cellular energy production and as a substrate for sirtuins, PARPs and other enzymes involved in DNA repair and cellular maintenance. Its decline with age has made it a focus of longevity research.

Research on NAD+ precursors (such as NMN and NR) and direct supplementation has examined effects on metabolic function, mitochondrial health and cognitive performance. Human data on direct injectable NAD+ is limited and individual responses vary.

NAD+ is supplied as a compounded injectable product following assessment and practitioner review. This is not a TGA-approved treatment for any specific indication.

Commonly considered for

Cellular energy support

Involved in the electron transport chain and mitochondrial function central to cellular energy production.

DNA repair pathways

Acts as substrate for PARP enzymes involved in DNA damage repair.

Sirtuin activation

Sirtuins — enzymes linked to longevity research — require NAD+ for their activity.

Cognitive and neurological research

Studied in the context of brain energy metabolism and neuroprotection.

How it works

Signal

NAD+ is delivered directly to tissues via subcutaneous injection, bypassing gut absorption limitations.

Response

Cells use NAD+ as a cofactor for energy production, DNA repair enzymes and longevity-associated proteins (sirtuins).

Monitoring

Blood panels and metabolic markers may be reviewed to assess response and identify any concerns requiring adjustment.

Often stacked with

Suitability, cautions and safety

Important: This information is for educational purposes only. It does not replace assessment, diagnosis or medical advice from a qualified clinician. Suitability varies by individual health history, medications and circumstances.

Existing cancer treatment

NAD+ supports cellular energy, which may have uncertain effects in the context of cancer or active treatment. Clinical review is essential.

Cardiovascular conditions

High-dose NAD+ can transiently affect heart rate in some individuals. Discuss with a clinician if you have a cardiac condition.

Pregnancy, breastfeeding or trying to conceive

Safety data is insufficient. Clinical guidance required.

Autoimmune conditions

Effects on immune cell activity require assessment in people with autoimmune conditions or immunosuppressive therapy.

Medications affecting metabolism

NAD+ interacts with various enzymatic pathways. Disclose all medications.

Answer each question honestly. If you answer Yes to any question, we recommend discussing this compound with a qualified clinician before proceeding.

Do you currently have cancer or are you undergoing cancer treatment?

Do you have a diagnosed cardiovascular or cardiac rhythm condition?

Are you pregnant, breastfeeding or trying to conceive?

Do you have an autoimmune condition or are you taking immunosuppressant medication?

Are you using other injectable compounds or significant supplement combinations?

Adverse effects and safety signals

Common effects

Generally mild and often resolve without intervention. Monitor and report if persistent.

  • Flushing or skin warmthCommon during or after administration. Usually brief.
  • NauseaParticularly at higher doses.
  • Headache
  • Injection-site discomfort
  • Fatigue or energy fluctuation initially

Discuss promptly with a clinician

If any of the following occur, stop use and contact your prescribing practitioner.

  • Persistent rapid heartbeat
  • Significant or prolonged flushing
  • Repeated vomiting
  • Dizziness or presyncope

Seek emergency help immediately

If you experience any of the following, call emergency services (000 in Australia) immediately. These may be signs of a serious allergic reaction or medical emergency.

  • Difficulty breathing
  • Facial, lip or tongue swelling
  • Widespread hives or rash
  • Collapse or fainting

Important: Before use, tell your practitioner if you have ever had an allergic reaction to any peptide, injection product or medicine. Allergic reactions can occur even with first use. I understand that I should seek urgent medical help if I experience signs of a serious allergic reaction.

Medications and interactions

Medicines and treatments to discuss

NAD+ may interact with medications affecting cellular energy pathways, chemotherapy agents, alcohol metabolising pathways and supplements targeting similar longevity pathways (e.g. resveratrol, NMN, NR). Disclose all current treatments.

Bloodwork and monitoring

The following tests may be considered at baseline and during use. Your Zenith practitioner will advise on what is relevant for you.

Baseline (before use)

  • Full blood count
  • Liver function
  • Fasting glucose
  • Lipid profile

Administration

  • Administer by subcutaneous injection. Some protocols use IV administration — follow your specific protocol card.

  • Rotate injection sites to reduce local tissue changes.

  • Slow administration is recommended to minimise flushing.

  • Use a fresh needle for each injection and dispose of sharps safely.

Storage and handling

  • Store refrigerated at 2–8°C.

  • Once activated, use within 28 days when refrigerated.

  • Do not freeze.

  • Protect from light. NAD+ is light-sensitive.

Research context: Extensive research on NAD+ precursors and direct supplementation in ageing and metabolic studies.

Frequently asked

Regulatory and classification note: Injectable NAD+ is a compounded product supplied following practitioner review. It is not TGA-approved for the indications described. This information is educational and does not constitute medical advice.

Regulatory & safety information

NAD+ is supplied subject to suitability assessment and applicable UAE regulatory requirements. Information provided is general and is not a substitute for professional medical advice, diagnosis or treatment.

Always consult a qualified healthcare professional before starting, changing or stopping any product, particularly if you are pregnant, breastfeeding, under 18, or managing a medical condition.

Why treatment isn't self-selected

Treatment decisions need context.

Selecting a treatment option is the starting point. What's clinically appropriate for you is determined by three things together.

Your bloodwork

Relevant biomarkers help identify which treatment options may be appropriate — and which should be avoided.

Your health history

Existing conditions, medications and goals are considered alongside your results, not in isolation.

Practitioner review

A licensed practitioner reviews every request before anything is approved, dosed or supplied.

Before you choose

Your bloodwork can change the conversation.

Recent bloodwork gives your practitioner more to work with — helping identify what may be appropriate, what should be avoided, and where a different option might be better suited to your results.

Already uploaded results? Your practitioner reviews them alongside any treatment request — no need to repeat information.

Optional at this stage. Required before final approval.

Purchase

NAD+

Supplied following assessment, bloodwork and practitioner review.

Price

A$399

From

A$399

1
Start Assessment

Supplied following assessment, bloodwork and practitioner review.

Ready to start?

Complete an assessment and get access to NAD+ through a tailored protocol.

Begin Assessment